<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04168567</url>
  </required_header>
  <id_info>
    <org_study_id>R18068</org_study_id>
    <nct_id>NCT04168567</nct_id>
  </id_info>
  <brief_title>The Impact of Body Mass Index in the Endometrial Microbiome in IVF Treatments</brief_title>
  <official_title>A Protocol for a Prospective Study to Compare Endometrial Microbiome in Patients Having Body Mass Index Over 30 Versus 20-25</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective trial with 90 patients suffering from the male type infertility.
      Patients are divided in two groups (45 patients per group) on the grounds of body mass index
      (BMI). .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is going to clarify endometrial, vaginal and anal microbiome variety between obese
      and normal weight patients. In the first group, the body mass index (BMI) of patients will be
      higher than 30 and in the other group, patients will be in their normal weight BMI 20-25. The
      samples are going to be examined in the time of the embryo transfer and microbiome will be
      analyzed in laboratory specialized in NGS techniques.

      Patient recruitment has not started because of testing of analyzing methods
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiome variety between groups</measure>
    <time_frame>through study completion, 1-2 years from the starting date</time_frame>
    <description>Differences in endometrial, vaginal and anal microbiome between obese and normal weight patients. Sample will be taken at the moment of embryo transfer with embryo catheter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>up to 2-3 months</time_frame>
    <description>Ongoing pregnancy rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>Obese patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who have BMI higher than 30</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal weight patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who have BMI between 20 and 25.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microbiome analysis</intervention_name>
    <description>Samples from the vagina, endometrium and anus and analyzing microbiome with NGS technique.</description>
    <arm_group_label>Normal weight patients</arm_group_label>
    <arm_group_label>Obese patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with male infertility and scheduled IVF treatment and fresh embryo transfer

          -  Primary or secondary male type infertility

          -  BMI over 30 kg/m2 or 20-25 kg/m2

          -  Patient's willingness to participate

        Exclusion Criteria:

          -  Patients with endometriosis or adenomyosis

          -  Antibiotics during IVF treatment or ovum pick-up

          -  Technical diffuculties in embryo transfer or no embryos to transfer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katja Ahinko</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katja Ahinko</last_name>
    <phone>+358 311611</phone>
    <email>katja.ahinko@pshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Riikka Leppänen</last_name>
    <email>riikka.leppanen@pshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riikka Leppänen, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 19, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Microbiome</keyword>
  <keyword>Microbiota</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

